North American Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,059
Closed -$220K 120
2018
Q3
$220K Buy
+1,059
New +$209K 0.04% 124
2018
Q1
Sell
-2,078
Closed -$361K 129
2017
Q4
$361K Buy
2,078
+19
+0.9% +$3.36K 0.06% 105
2017
Q3
$384K Hold
2,059
0.06% 103
2017
Q2
$355K Hold
2,059
0.06% 109
2017
Q1
$338K Hold
2,059
0.05% 109
2016
Q4
$301K Hold
2,059
0.05% 113
2016
Q3
$343K Hold
2,059
0.06% 112
2016
Q2
$313K Hold
2,059
0.05% 115
2016
Q1
$309K Hold
2,059
0.05% 119
2015
Q4
$334K Hold
2,059
0.05% 116
2015
Q3
$285K Buy
+2,059
New +$325K 0.05% 131

Other funds holding AMGN

North American Management's AMGN Position: Q4 2018 in Review

North American Management sold out of Amgen (AMGN) in Q4 2018, closing a stake of 1,059 shares — an estimated $220K sold.

North American Management first reported a position in AMGN in Q3 2015 and held it in 11 quarters. The position peaked at $384K in Q3 2017. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • North American Management reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • North American Management sold 1,059 Amgen shares in Q4 2018, an estimated $220K.
  • North American Management first reported a position in Amgen in Q3 2015 and held it in 11 quarters.
  • North American Management's Amgen position peaked at $384K in Q3 2017.
  • 1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on North American Management's 13F filing for Q4 2018, filed 8 Feb 2019.